Nanomedicine is a promising application of nanotechnology in medicine, which can drastically improve drug delivery efficiency through targeted delivery. However, characterization of the nanoparticle targeted delivery process under vascular environment is very challenging due to the small scale of nanoparticles and the complex in vivo vascular system. To understand such complicated system, various computational models are developed to help reveal nanoparticle targeted delivery process and design nanoparticles for optimal delivery. This article discusses a few computational tools to model the nanoparticle delivery process and design nanoparticles for efficient targeted delivery. The modeling approaches span from continuum vascular flow, particle Brownian adhesion dynamics, to molecular level ligand-receptor binding. Computer simulation is envisioned to be able to optimize drug carrier design and predict drug delivery efficiency for patient specific vascular environment.
INTRODUCTION
Nanotechnology refers to the study of matter on nanoscale, in general dealing with structure size in between 1 to 100 nm in at least one dimension. 1 Nanotechnology represents a broad range of applications; the medical application of nanotechnology refers to "nanomedicine". Nanomedicine based drug delivery system hold great promise in the next generation of medicine to improve human health. Among all different research branches, drug delivery contributes over 70% of scientific papers in nanomedicine research field. 2 The aim of drug delivery is to improve patient treatment by enabling the administration of new intricate drugs, improving the bioavailability of existing drugs, and providing spatial and temporal targeting of drugs in order to dramatically reduce side effects and increase effectiveness. Through accomplishment of these revolutionary advantages, patients and physicians could benefit from personalized prescriptions, alleviated administration, increased patient compliance, reduced dosage frequency and less pain. Over the past decade, we have witnessed an explosive development of nanoparticulate systems for diagnostic imaging and targeted therapeutic applications. [3] [4] [5] [6] [7] [8] [9] [10] Various nanoplatforms, including liposomes, 11 12 polymeric micelles, [13] [14] [15] [16] quantum dots, 17 18 Au/Si/polymer shells, [19] [20] [21] and dentrimers [22] [23] [24] etc. have been developed. Although recent data on in vivo nanoparticle (NP) drug delivery has showed remarkably improved efficacy over traditional drug, yet the challenges in nanomedicine field are many.
For example, the study of drug delivery system is not straightforward process, which requires further consideration and comprehensive analysis. The targeted drug techniques such as Molecular dynamics, Brownian motion, and stochastic approaches such as Monte Carlo simulation to capture the nanoparticle motion. For example, Shipley et al. 27 and Modok et al. 28 modeled delivery of spherical NPs in tumor. Mahmoudi et al. 29 and Li et al. 30 performed computational fluid dynamics studies of magnetic NPs in vascular flow. Liu et al. 31 and Zhang et al. 32 studied the deposition of NPs in lung airway. Figure 2 shows a multiscale simulation framework for targeted drug delivery ranging from continuum model to particular model. It's the recent advancement in the computational science that made computational modeling very promising for targeted drug delivery application. The ligand coated nanoparticles, loaded with drugs inside, transport in blood stream, and adhere to diseased cells via specific adhesion. However, this process becomes intricate due to simultaneous involvement of hydrodynamic force, adhesion force and Brownian force. In particular, the ligand-receptor interaction is a sophisticated chemical process. The surface property of functionalized nanoparticles would play a crucial role to dictate the efficiency of the targeted drug delivery by providing targeted selectivity. Computational modeling tool will lead to insights of the dynamic delivery process, thus facilitate better design of nanoparticles. This article focuses on multiscale computational approach to the targeted drug delivery. First, continuum based drug delivery model is introduced, which covers the basic governing equations and a few examples of targeted drug delivery under vascular conditions. Second, particulate modeling based on coupled Brownian adhesion dynamics method is described, where the motion and binding of individual nanoparticles in the blood stream are modeled. Finally, the future trend in computational modeling of targeted drug delivery is briefly discussed.
CONTINUUM APPROACH: DRUG DISSOLUTION TO CONVECTION-DIFFUSION-REACTION MODEL OF DRUG DELIVERY

Introduction
In vivo drug release, transportation and targeted binding have been recognized as important elements in targeted drug delivery field. In order to target the disease area, the drug loaded carriers are first injected into the circulation system, where they transport through, across and within vessels, tissues and cells. Due to specific binding between ligand coated drug particles and receptors, expressed at the disease cell membrane, drug loaded particles deposit on the targeted disease region. Afterward process is followed by cellular uptaking and drug releasing. From the continuum stand point of view, the drug delivery process consists of drug dissolution, transport and binding, which can be described by mass conservation law and chemical kinetic reaction.
In recent years, in vitro release profile of drug from controlled release platform has been combined with the state of art Computational fluid dynamics (CFD) simulation to predict the the spatial and temporal variation of the drug transport in the living tissues. For example, Saltzman and Radomsky 33 developed a diffusion kinetics model for the drug release in the brain tissue. The transport mechanism was assumed to be mainly governed by diffusion due to the selective permeability of the blood capillaries known as blood-brain-barrier. This simplified model's prediction has been validated by the experimental data of drug spatial distribution. A three dimensional (3D) simulation of 34 The simulation is conducted on CFD tools to solve simultaneously continuity, momentum and drug concentration equations. Using their model, the contribution of convective transport of macromolecular and micromolecular drugs in the vicinity of tumor were studied. In this section, the governing equations of the continuum drug delivery model are described and a few demonstration examples are presented.
Dissolution of Drug Particles
A number of mathematical models have been proposed and effectively applied to describe the drug release and dissolution in literature. [35] [36] [37] [38] The simplest form of drug dissolution profile is zero order kinetics that assumes slow drug releasing process,
Where Q 0 is the initial amount of drug in the pharmaceutical dosage form, Q t is the amount of drug in the pharmaceutical dosage form at time t and K is a proportionality constant. Dividing the above equation by Q 0 simplifying it to:
Where f t = 1 − Q t /Q 0 is often referred as fraction of drug. This relation can be used to describe the drug dissolution of several types of modified pharmaceutical dosage release forms, particularly with low soluble drugs.
First Order Kinetics
The application of this model was first proposed by Gibaldi and Feldman, 39 and later by Wagner. 40 The dissolution rate of the drug is described by the Noyes-Whitney equation as shown below:
Where C is the concentration of solid in bulk dissolution medium, C s is the concentration of solid in diffusion layer surrounding solid, K is a first order constant and it is associated with surface area of the solid drug, diffusion coefficient and diffusion layer thickness.
Since the dissolution mechanism of drug is very complex, various empirical equations are proposed to describe this process. For example, the popular Weibull equation expressed the fraction of drug, m at time t, in the simple exponential form:
Where a is time related constants, T i represents time lag before onset of the dissolution, b is a curve characterized parameter.
Higuchi 38 formulated following relation to model low soluble drug release problem:
Where C is the drug initial concentration, C s is the drug solubility in the matrix media and D is the diffusion coefficient of the drug molecules in the matrix substance.
A few other models are summarized in a review paper by Paulo Casta et al. 41 The commonly used mathematical models are listed in Table I .
Convection-Diffusion-Reaction Model of Drug Delivery
The concentration of nanoparticle c inside a vascular system can be described by the convection-diffusion equation:
Where c is the concentration of nanoparticles, D is the diffusion coefficient of nanoparticle and U is the flow velocity. It is solved by using following Einstein-Stokes equation,
Where k B is the Boltzmann constant, T is the temperature, is the viscosity of fluid medium and r is the NP radius. The biorecognition of the targeted drug delivery site is similar to a key lock mechanism which is in reality a complex biochemical reaction. To depict the effect of adsorption of nanoparticles on a functionalized surface, Langmuir reaction model is employed. 42 The ligand-receptor binding process is a weak reversible process, which leads to continous attachment and detachment of nanoparticles. 43 The material balance for the active surface including surface diffusion and the reaction rate expression for the formation of the adsorbed species c s is defined by:
Where D s is the surface diffusivity (m 2 /s), c w is the bulk concentration of the species at solid wall (unit mol/m 3 , is the surface concentration on the active site (mole/m 2 Table I . Mathematical models used to describe drug dissolution curves. 
Zero order
In above equation, 0 represents the total number of active sites available on the active surface. Convection-diffusion equation and nanoparticle reaction equation are not independent, instead, they are coupled through Fick's law:
Nanoparticle Binding in a Channel
To demonstrate application of continuum model in targeted drug delivery, finite element modeling is used to evaluate the nanoparticle transportation diffusion and biochemical reaction dynamics in a channel. In this model, the convection diffusion in 2D fluid domain is coupled with the adhesion reaction occurring on the reaction surface (disease site). When a portion of the blood vessel is injured, significant P-selectin is expressed on damaged endothelial cells, which can be targeted by nanoparticles coated with GPIb ligand. In this model, the convection-diffusion process of nanoparticle in 2D fluid domain is coupled with the adhesion reaction occurring only on the reaction surface which mimics the target site for drug delivery. The physical parameters used to create this model are listed in Table II . To initiate adhesion, nanoparticles must stay close to the vessel wall, inside the so called depletion layer also known as a near-wall layer where adhesion process take place. The thickness of the depletion layer is largely influenced by the flow rate, evident from the simulation result shown in Figure 3 . When drug particles bind with the receptors coated surface, drug concentration drops near the surface, effectively forms a "depletion layer" near the wall. Figure 3 shows the depletion layer at shear rates 0.1 mm/s and 1 mm/s respectively. As the flow rate increases the depletion layer thickness decreases due to greater nanoparticle flux and shorter retention time of the nanoparticles.
Nanoparticle Deposition and Distribution in a Blood Vessel Network
Another example application of continuum model is to determine nanoparticle deposition and distribution in a complex vascular geometry. Figure 4 shows the drug delivery process in an idealized vascular network with three generations. The physical parameters used to create this model in listed in Table III . Drug loaded nanoparticles of a given concentration are injected at the top inlet and are transported through the vascular network along with fluid flow. The left branch of the network is assumed to be a receptor coated target surface that can form bonds with ligands on drug loaded Blood dynamics viscosity nanoparticle surface. The particle depletion layer is clearly visible in the target region. The density of deposited drug particles on the wall surface is plotted in Figure 5 , which indicates that most drug particles are deposited at the entrance of the target region, while the rest of the target region has low density of deposited drug particles. There are no particles deposited in the healthy branch due to an assumption of zero non-specific adhesion at that particular location. Such non-uniform distribution pattern indicates possible impaired delivery dosage within the target region, which is important for delivery efficacy prediction and dosage planning.
PARTICULATE APPROACH: RATIONAL DESIGN OF NANOPARTICLES
Introduction to Nanoparticle Design
Most of the nanoparticles employed in the experimental studies are spherical in shape. Extensive studies have been dedicated to comprehend their biological behaviors in vitro and in vivo. For example, it is known that spherical particles bigger than 200 nm are efficiently filtered by the spleen, while particles smaller than 10 nm can be quickly cleared by the kidney, thus making 10-200 nm as an ideal size range for the spherical carriers. Similar to size, shape is a fundamental property of micro/nanoparticles that may be critically important for their intended biological functions. [44] [45] [46] [47] [48] [49] [50] Recent data begin to reveal that particle shape may have a profound effect on their biological properties. For example, cylindrically shaped filomicelles can effectively evade the non-specific uptake by the reticuloendothelial systems and persisted in the circulation up to one week after intravenous injection. From drug delivery stand point of view, non-spherical particles will allow larger payload delivery than the spherical counterpart with same binding probability. Recently, Mitragotri and coworkers have shown that the local shape of the particle at the point where a macrophage is attached, not the overall shape, dictated whether the cell began internalization. 51 These results indicate the importance of controlling particle shape for nanomedicine application.
Theoretical studies of nanoparticle deposition are typically focused on simple spherical or oblate shape. [52] [53] [54] Ideally, there should be a tool that can handle variety of shapes and sizes of nanoparticles, which enables endless possibilities of finding most suitable design of the nanoparticle for a given application. Decuzzi and Ferrari.
52-54 have studied the margination of nanoparticles in blood stream, where nanoparticles diffusion in Newtonian fluid has been analyzed. The same authors have also examined the adhesion probability of nanoparticles under an equilibrium configuration. Mody et al. 55 56 studied platelet motion near vessel wall surface under shear flow and concluded that hydrodynamic force influences platelet adhesion to the wall surface. The same authors 55 56 also investigated the influence of Brownian motion on platelet movement and found that Brownian motion does not influence plateletshaped cells at physiological shear rates. However, size (∼2 m) and shape (oblate) of the platelet is not comparable to that of nanoparticles and the behavior observed for platelet might not be applicable for nanoparticles.
Influence of Nanoparticles Size and Shape on Targeted Delivery
The targeted drug delivery process in general can be considered as a seamless combination of three stages: transport through the vessel network; adhesion process; and cellular update. Each stage is effectively governed by nanoparticle shape, size, and surface property. Specific combination of each parameter can accomplish efficient targeted delivery. There have been a large number of studies devoted on characterization of nanoparticle physical property. Djohari and Dormidontova 57 studied kinetics of spherical nanoparticle for targeting cell surface using dissipative particle dynamics. The shape of the adsorbed nanoparticle was found to become ellipsoidal with increasing binding energy. Janus-like nanoparticles with ligands coated on one side of the nanoparticle was observed to bind faster than that with uniformly coated ligands. Geng et al. 58 revealed the potential of non-spherical shaped carrier for drug delivery application. Figure 6 shows the results of their experimental study on the circulation time of filomicelles of different lengths in a mice model. Further, the same group performed in vivo study to investigate the shape effect and discovered that non-spherical shape carrier has 10 times longer circulation time compared to its spherical counterpart.
Muro et al. 59 studied controlled endothelial targeting and intracellular delivery by modulating size and shape of the drug carrier. Their study found that carrier geometry influences endothelial targeting efficiency. The non-spherical carrier had longer circulation time and higher targeting specificity than regular spherical carrier. Shah and Liu et al. 60 has compared the transport phenomenon and binding probability of nanospheres and nanorods under shear flow and revealed significantly higher binding efficiency of nanorods due to their tumbling motion and larger contact area. 46 Computational Modeling of Nanoparticle Targeted Drug Delivery adhesion probability of different shaped nanoparticles is discussed in the next section.
Theoretical Model of Nanoparticle Adhesion Probability
A numerical model is built based on the previous work by Decuzzi and Ferrari 52 65 to describe the cell targeting process of nanorods and nanodisks under flow conditions. The adhesion probability (P a is characterized by the probabilistic kinetic formulation of McQuarrie 66 and Decuzzi:
Where m r is the receptor density on the substrate surface, m l is the ligand density on particle surface, A c is the contact area of particle, f is force acting per unit ligand-receptor pair, k B T is thermal energy of system, is a characteristic length of ligand-receptor bond, and K o a is the affinity constant of ligand-receptor pair at zero load. Normalized adhesion probability of oblate-, rod-and discshaped nanoparticles for a wall shear stress of 1 (Pa) is plotted as a function of particle volume in Figure 7 . The aspect ratio of disc (diameter over height) and rod (length over diameter) are chosen to be 5.
As shown in Figure 7 , for the spherical particle with increasing particle volume, the adhesion probability increases first, due to larger available surface area for the bond formation, and then decreases due to the large volume. Particles of larger volume faces larger dislodging force, which overwhelms bond forces and get the particle washed away, thus reduces the adhesion probability. Due the shape effect, the critical volume of the non-spherical particles is comparatively large and shifts to the right side of the plot (out of the plot range). For the range of volume considered, the oblate, rod and disc particles show significantly higher adhesion probabilities than the Fig. 7 . Adhesion probabilities of nanoparticles of various shapes as a function of particle volume, is the aspect ratio. spherical particles of the same volume. Furthermore, the disc-shaped nanoparticles have the highest adhesion probability and the largest volume to the mass ratio, resulting in 300 times higher efficacy for cell targeting and 40 times higher drug-loading capability than their spherical counterpart. The adhesion probability of the rod-shaped particle, with the aspect ratio of 5, is about 20 times higher than the spherical particle. Similarly, the oblate shaped nanoparticles exhibit almost 10 times higher adhesion probability compared to the spherical particles over the entire range of volume considered.
This theoretical model is based the adhesion probability for a particle to adhere on receptor coated surface, but lacks in revealing dynamic process of nanoparticle transport and delivery. A coupled model that integrates margination with adhesion kinetics, and applicable to nanoparticle of various shapes, is yet to be developed. Thus, analysis of this process for an arbitrarily shaped nanoparticle through a multiscale model is crucial to provide biological insights on the transportation and adhesion kinetics. In what follows, we will first introduces the nanoparticle adhesion kinetics theory and modeling method. Then, adhesion process and trajectories for nanoparticles of different shapes and ligand densities are presented. Next, the binding probability of nanoparticles is determined for a range of channel sizes.
Particulate Model of Nanoparticle Delivery in a Vascular Environment
Nanoparticles are usually introduced into the vascular circulation stream through intravenous injection. [68] [69] [70] The targeted delivery efficiency is directly related to the nanoparticle selectively and ability to bind at the targeted site. Though highly selective nanoparticles have reduced binding probability in non-target regions, the majority of nanoparticles are still lost in the vascular network due to non-specific adhesion. It is thus important to predict vanished concentration of nanoparticles in the upstream and nanoparticle concentration when it reaches the targeted region. The focus of a particulate model is to explore an optimum design of nanoparticle to achieve high binding probability in the diseased region and high overall delivery efficiency under given vascular environment.
Nanoparticle Adhesion Kinetics
To achieve targeted drug delivery, nanoparticles are usually coated with ligands that bind specifically to a particular type of receptors expressed on the diseased vessel cell surface. 71 Once nanoparticles marginate to vascular surface, the ligand coated nanoparticles interact with the specific receptors expressed at target surface. Such interaction results in a bond formation between nanoparticle and 53 Thus, these factors are neglected for this model. The ligand-receptor binding process is integrated with Brownian dynamics and this combined model is embedded into the Immersed Finite Element (IFEM) platform. [72] [73] [74] [75] IFEM can be used for fully coupled fluid-structure interaction problems, i.e., solving particle motion in a fluid while capturing the influence of particle on fluid flow. However, due to Brownian motion, it is computationally expensive to calculate the change of fluid flow caused by particle motion at every time step. Also, the effect of nanoparticle motion is limited to the local surrounding region. Thus, the influence of particle motion on the fluid flow is neglected and the model is only solved for the particle motion and the adhesion process.
When a particle approaches the vascular wall, ligands on the particle surface form bonds with receptors on the vascular wall, as demonstrated in Figure 8 . An adhesion kinetic equation is used to calculate the bond density N b :
Where N l and N r are the ligand and receptor densities; k r and k f are the reverse and forward reaction rates, respectively. This interaction model represents a conservation equation of the different species (ligands, receptors, and bonds). The k r and k f are function of bond length:
Where k s is the bond elastic constant; k ts is the bond elastic constant at transient state; B z is thermal energy; k k 0 f are the reverse and forward reaction rates at zero load of ligand-receptor pair, respectively; L is the difference between bond length y and equilibrium length . During dynamic interaction process, the bond length of a ligandreceptor pair may vary based on particle location. The ligand-receptor bonds are modeled as springs with spring constant and equilibrium length , thus the bond forces are described as a function of bond length y. Then, the ligand-receptor interaction forces can be summed on finite element surface through integration over the nanoparticle surface. Equations of bond forces f L and integrated adhesion forces s on particle surface are given as:
Such adhesion force is coupled with the fluid-structure interaction (FSI) force in the IFEM formulation. Similar adhesion model has been used by Chang et al. 77 and Dong et al. 78 in the study of white blood cell rolling. The physical parameters used in the model are listed in Table IV .
Besides adhesion forces, the Brownian force acting on to the nanoparticles is also important and is integrated into the IFEM formulation by adding a Brownian force term, which is described in the next section.
Brownian Dynamics at Nanoscale
Fundamental theories of Brownian dynamics have indicated that random collisions from surrounding liquid molecules impacts motion of an immersed small particle. [79] [80] [81] The influence of Brownian motion on behavior of nanoparticles in microfluidic channel and platelets and blood cells in blood flow has been studied extensively. [82] [83] [84] [85] Patankar et al. 86 have proposed an algorithm for direct numerical simulation of Brownian motion by adding random disturbance in fluid. At microscale, the drag force acting on particles such as blood cells is significantly large (>50 pN for particle size >1 m), thus Brownian motion is neglectable. 82 At nanoscale, Brownian force becomes a dominant force to drive nanoparticle near vascular wall surface, while the drag force acting on a nanoparticle is relatively small. Shah and Liu et al. 60 developed novel hybrid model to study Brownian dynamics at nanoscale and governing equations are described as following.
The random forces R t and torque T t acting on a nanoparticle is responsible for Brownian motion and rotation and satisfy the fluctuation-dissipation theorem: Where is the unit-second order tensor, ij is the Kronecker delta, t − t is the Dirac delta function, k B T is thermal energy of system, t and r are the translational and rotational friction coefficient of nanoparticle, respectively.
The friction coefficient depends on several physical parameters, such as fluid viscosity, size and shape of the nanoparticle. The friction coefficient for spherical-shaped particles can be easily derived from Stokes' law. However, there is no empirical formula available for determining the friction coefficient of particles with complex shapes. In literature, there are empirical formulas for friction coefficients for particles, but limited to simple shapes and orientations such as oblate or rod-shaped particles. [88] [89] [90] [91] In a recent work by Loth, 92 new empirical formula is proposed to compute friction coefficient for a non-spherical particle. Friction coefficient of rod shaped particles in this work is derived based on Loth 92 and extended with an angle factor to incorporate arbitrary orientations. When a particle travels along the fluid flow, the relative velocity of the particle can be divided into components in two directions: parallel to flow and perpendicular to flow, as shown in Figure 9 . The friction coefficient of a rod-shaped particle for an arbitrary orientation is given by Ref. [92] :
Where is the fluid viscosity, d eqv is the diameter of particle volume equivalent sphere, is the angle between flow direction and the long axis of the particle, f and f − are Stokes correction factors for a spheroid particle moving parallel and perpendicular to the flow, respectively. These correction factors are expressed as Ref. [92] :
Where is the aspect ratio of the spheroid particle. The velocity of a particle moving under a deterministic force in a fluid with velocity V f is given by:
Where F det is the total deterministic force acting on the nanoparticle (including Brownian force, adhesion force, etc.), V s and V f are the solid and fluid velocity vectors, respectively. For a time step (typically ∼1 s) much greater than characteristic time constant m/ t (∼10 ns), the nanoparticle moves with a terminal velocity, thus Eq. (23) reduces to:
Equation (24) actually describes that the deterministic force acting on a particle is balanced by the drag force from the fluid. This is reasonable since the mass of a nanoparticle is so small that inertia effect can be neglected. This terminal velocity is then use to update the nanoparticle position in translational direction. Similarly, the angular velocity of a nanoparticle can be obtained through: Where f is the angular velocity due to fluid flow. Combining the translational and angular velocities, particle nodal positions are updated based on its distance from the particle center as:
The fluid flow in our simulation is assumed to be an incompressible viscous fluid governed by the Navier-Stokes equations:
It should be noticed that v f is the fluid velocity in the fluid main, while V f is the fluid velocity interpolated onto the solid domain. The Navier-Stokes equations are solved through finite element method. To reduce numerical oscillations, the velocity test function is employed along with stabilization parameters. Using integration by parts and the divergence theorem, the Patrov-Galarkin weak form is obtained. Then, the nonlinear system is solved using the Newton-Raphson method. Moreover, Generalized Minimum Residual (GMRES) iterative algorithm is employed to improve computation efficiency and to compute residuals based on matrix-free techniques. 93 Details of the implementation can also be referred to Zhang et al. and Liu et al.
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Simulation Results of Nanoparticle Targeted Delivery Process
Mathematical modeling of targeted drug delivery system provides quantitative description of the drug transportation in biological systems. Therefore, it can be utilized to evaluate efficiency of drug delivery and to estimate dose response.
Effect of Nanoparticle Shape on Adhesion Kinetics
The following section discusses about influence of nanoparticle geometry on adhesion kinetics. Two separate sets of simulation studies have been performed to evaluate near wall behavior of spherical particle and non-spherical particle.
Comparing Deposition Process of Nanoparticles. To investigate the influence of nanoparticle shape on adhesion kinetics, two nanoparticles of different shapes, spherical and non-spherical, but of the same volume are considered in this study. The length of the rod shaped particle considered is 1000 nm with an aspect ratio of 5. The diameter of spherical particle is 380 nm. Such constant volume comparison helps to understand whether nanorod or nanosphere bind easily to wall surface for a given drug load capacity. The simulations are carried over a channel of 5 m long and 2 m high. In the simulation, a spherical particle and a rod-shaped particle are initially positioned with their centers 600 nm above a receptor-coated surface, as shown in Figure 10 .
A velocity is applied at the top of channel to generate a shear rate of 8.0 s −1 . Nanoparticles are allowed to move freely through the channel under the influence of shear flow and Brownian forces. For a typical simulation demonstrated in Figure 10 , the spherical particle fails to make any contact with the vessel wall while it travels through the channel. Under given velocity and channel length, Brownian diffusion is not large enough to make the spherical particle to reach close enough to the wall surface to initiate binding process. Compared to nanospheres, nanorods make contact and adhere to vessel wall quickly and frequently. The rod-shaped particle exhibits tumbling motion by virtue of non-spherical shape while flowing through the channel. Due to the tumbling motion, a nanorod usually contacts with the receptor coated wall with bonds formed at the long axis end first. Such initial contact is followed by nanoparticle rotation along the contact end and steadily growing adhesion force, which ensure firm adhesion to the vessel wall and at the end settle down at equilibrium state with full contact. The simulation results reveal typical trajectories of a nanosphere and a nanorod, which illustrate different dynamic adhesion processes. A more quantitative description of the adhesion process will be presented in later sections.
One question that might arise at this point is the existence of such near wall particle tumbling motion. In literature, tumbling of non-spherical particles near a wall surface has been reported. 56 95 96 The combined effects of shear flow and Brownian rotation have been found to enhance rotation of nanorods. 97 98 Comparing Trajectories of Nanospheres and Nanorods. Nanorods are expected to have higher probability to contact with the wall surface than their spherical counter parts because of tumbling motion. To test this theory, trajectories of spherical and non-spherical nanoparticles under the same flow condition are compared. A shear rate of 8.0 s To illustrate the fluctuations of nanoparticle-wall distance, minimum distance between the nanoparticle surface and the wall surface is recorded over the time, as shown in Figure 11 (A). Such nanoparticle trajectory indicates the path of nanoparticle during its motion through the channel. In a series of simulation runs, a nanosphere and a nanorod are placed initially 650 nm above the wall surface. The trajectories of nanorod and nanosphere of 20 independent simulations are plotted in Figure 11(B) .
The simulation result elucidates that a nanorod has larger fluctuations in trajectories due to tumbling motion, thus it has more contact/adhesion events compared to that of nanosphere, as shown in Figure 11 (C). Moreover, in a fixed number of trials, ten nanorods are deposited while only three nanospheres are deposited. Probability of spherical particle to contact with wall surface solely depends on Brownian diffusion; while in case of non-spherical particle, probability of contact is enhanced by tumbling motion. Thus, this result indicates that nanorod has higher contact probability than the nanosphere for given physiological flow condition.
Nanoparticle Binding Probability
The simulation method developed in previous sections is a rigorous way to model the full transportation and adhesion dynamics of arbitrarily-shaped nanoparticles. However, to model the adhesion process of large number of nanoparticles, it is computationally cost-effective and more convenient to derive a binding probability for nanoparticles under various configurations. The binding probability is the probability of a nanoparticle located within a certain distance from the wall surface to bind with the vascular wall. Binding probability directly determines how many nanoparticles will actually bind to the wall surface among total number of nanoparticles present within the fluid channel considered? This is an important parameter to determine drug concentration for desired application. It should be noted that only nanoparticles are considered in this particular section. Blood cells have been observed to influence the dispersion rate of nanoparticles. However, the focus of this section is to characterize the influence of particle shape on its binding property. Although, multi-scale model that can handle blood cells along with nanoparticle would certainly be covered in future requiring further study and development. Now, it is known that to initiate bond formation, nanoparticles must stay very close to the wall surface, inside a cell free layer (CFL) or depletion layer, 99 as shown in Figure 12 . The red blood cells flow with relatively higher velocity in the core region of vessel, leaving a pure plasma region with lower velocity close to vessel wall. The existence of CFL makes it reasonable to only consider nanoparticles in the deposition process. The thickness of the cell free layer is found to be varying from 2-5 m, independent of vessel size for vessels with diameter above 20 m. [100] [101] [102] This suggests that binding probabilities of nanoparticles should be studied for a range of depletion layer or CFL thicknesses.
This particular section focuses on studying the effect of two parameters; shear rate and depletion layer thickness, on nanoparticle binding probability. To ensure consistency and study sole effect of mentioned parameters among all the cases, the rest of the parameters are kept constant. For example, the value of ligand density is assumed to be sufficiently high to guarantee firm adhesion of nanoparticles (adhesion force typically varies between 1 pN-100 pN, while dislodging forces are limited around 0.01 pN). Moreover, it has been shown recently that once a nanoparticle tethers to the receptor coated surface, it is unlikely to get detached under hydrodynamics force 103 due large adhesion force which overwhelms other forces present that scale. As a result, this section focuses on determining binding probability of nanoparticles rather than dissociation probability. The simulation parameters are listed in Table IV , unless otherwise noted. The diameter and length of nanorod is 200 nm and 1000 nm, respectively. The diameter of nanosphere is 380 nm.
The simulation begins with randomly assigned initial positions of nanoparticle at the channel inlet. Range of shear velocities is applied at the top of the channel to generate different shear rates. The nanoparticle transportation is simulated by the Brownian adhesion dynamics model as discussed in the previous section. To ensure statistical accuracy, binding probability is evaluated based on the results of 200 independent trials. The number of bonded nanoparticles is counted and normalized by the total number of nanoparticles to obtain the binding probability for a given depletion layer thickness under a given flow condition. Binding probability of nanoparticles as a function of depletion layer or CFL thickness is plotted in Figure 13 for two different shear rates, 10 s −1 and 2 s −1 , respectively. The nanorods show significantly higher adhesion probability than the nanospheres at both shear rates. Figure 13(A) shows the binding probability of nanoparticles under a shear rate of 10 s −1 . As the CFL thickness increases, binding probability of nanoparticle decreases. Due to limited diffusion length, the binding probability of a nanosphere decreases almost linearly with CFL thickness, except for low CFL thickness of 1.5 m. At 1.5 m CFL thickness, the size of nanoparticle becomes comparable to the CFL thickness, thus results in higher deposition probability. In comparison, the binding probability of nanorod decreases almost quadratically with CFL thickness, mainly due to the tumbling motion. In particular, a nanorod has significantly higher binding probability than nanosphere at smaller CFL thicknesses. As shear rate decreases, binding probabilities for both particles increase. At a shear rate of 10 s −1 and CFL thickness of 1.5 m, the binding probability of the nanorod is around 2.5 times of that for the nanosphere. At a shear rate of 2 s −1 , the difference in the binding probability between nanorod and nanosphere is reduced, as shown in Figure 13 (B). At lower shear rates, Brownian motion becomes a dominant factor, thus it overwhelms the contribution of tumbling motion.
Besides shape, the effect of nanoparticle aspect ratio is also investigated. Nanorods of two aspect ratios (5 and 10) are considered in the study and compared with nanosphere. The binding probability of nanoparticles under different shear rates is plotted in Figure 14 . A depletion layer thickness of 5 m is considered for the study. It is found that nanoparticle with higher aspect ratio has higher binding probability than that of lower aspect ratio or spherical nanoparticles. The binding probabilities for nanorods are proportional to the aspect ratio with a scaling factor of around 1.6 in a range of shear rates. The simulation result also elucidates that increase in shear rates reduces binding probability of nanoparticles, but the degree of reduction of binding probability varies with different aspect ratio of nanoparticles. Binding probability of nanosphere drops largely with increase in shear rate. While that of nanorods drops only marginally with increase in shear rate. This result clearly demonstrates advantage of nanorod over nanosphere in terms of binding probability over a range of shear rates. 
FUTURE TREND
The future of nanoparticle based targeted drug delivery is very promising. We have witnessed exponential growth of research related to nanoparticle based drug delivery in the past decade. Engineering design of drug carrier is playing an important role in nanomedicine field. To improve efficiency, magnetic particles have also been proposed to offer better imaging property and targeting efficiency under localized magnetic field compared to polymer particles. 104 The large variety of material selection (metallic or nonmetallic particles), sizes (10 nm to 200 nm), shape (spherical or non-spherical), and complex vascular conditions (healthy or tumor vasculature) have raised needs on faster and efficient nanocarrier design. It is very time consuming and challenging task for researchers to predict behavior of various nanocarriers under physiological environment. Owing to the limitation of experiments, computational . Nanoparticle deposition and distribution in vascular geometry reconstructed from MRI scanned images. 61 work would be crucial tool for engineering shape and size of these nanocarriers. As a result, there have been a significant growth in the number of papers on modeling nanoparticle targeted delivery published lately 46 60 61 105 106 as shown in Figure 15 .
CONCLUSION
Multi-scale modeling of targeted drug delivery system provides quantitative description and in-depth analysis of the drug transportation and delivery process in dynamic biological system. Such detailed results are very useful to determine delivery efficiency of particular nanocarrier for a given vascular condition and indeed to estimate dose quantity and toxicity. An accurate computational model needs to represent the actual physiological condition of drug delivery. Most current studies focus on modeling nanoparticle transport and binding under idealized vascular environment such as simple straight and branched channels. To mimic the real vascular environment, the vascular geometry could be reconstructed from CT/MRI scanned images. The simulated nanoparticle deposition in a branch vessel reconstructed from MRI scanned images is shown in Figure 16 . Such virtual tool can be used to predict nanocarrier bio-distribution and the delivery efficiency under a given patient vascular geometry and hemodynamic conditions, and help design nanoparticles for maximum targeting efficiency and minimum drug dosage. 
